Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

The Hope Dealers: How Clinicians and New Tech Could End Unnecessary PAD Amputations

News Features

The Hope Dealers: How Clinicians and New Tech Could End Unnecessary PAD Amputations

December 24, 2020

The finding, from a study with a mean follow-up of 2-and-a-half years, bolsters support for trials and device use to continue.

News Daily News

SWEDEPAD: No Mortality Signal With Paclitaxel in PAD

December 18, 2020

Mahesh Anantha, MD

News Featured Fellow

Mahesh Anantha, MD

Yael L. Maxwell

October 12, 2020

CV Prevention Meds Underused in Hispanic, Latinx PAD Patients

News Daily News

CV Prevention Meds Underused in Hispanic, Latinx PAD Patients

August 12, 2020

Newer, Thinner-Strut Abbott Scaffold Prompts Talk of a BVS Comeback

News Conference News CRT 2020

Newer, Thinner-Strut Abbott Scaffold Prompts Talk of a BVS Comeback

Michael O'Riordan

February 28, 2020

Common-Femoral Lesions: LINC 2020 Experts Hash Out the Best PAD Treatment

News Conference News LINC 2020

Common-Femoral Lesions: LINC 2020 Experts Hash Out the Best PAD Treatment

January 31, 2020

Lutonix BTK Studies: Below-the-Knee Challenges Linger

News Conference News LINC 2020

Lutonix BTK Studies: Below-the-Knee Challenges Linger

January 29, 2020

Leaving the Hospital Nest? OBL Advice From Those Who’ve Done It

News Conference News ISET 2020

Leaving the Hospital Nest? OBL Advice From Those Who’ve Done It

January 28, 2020

News Conference News ISET 2020

FDA’s First Take on New Paclitaxel Concerns in CLI

January 24, 2020

PAD Care on the Backdrop of Cancer Requires Creativity, Persistence

News Conference News ISET 2020

PAD Care on the Backdrop of Cancer Requires Creativity, Persistence

January 23, 2020

News Daily News

Paclitaxel DCBs Now Implicated in Death, Amputation in Below-the-Knee CLI

January 15, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.